8-K: Sleep Number Exceeds FY25 EBITDA Guidance Amid Turnaround

Sleep Number Corporation reported full-year 2025 net sales of $1.4 billion, exceeding adjusted EBITDA guidance, while navigating industry demand pressures and launching new products.

Summary

• Full-year 2025 net sales were $1.4 billion, a 16% decrease year-over-year, driven by ongoing industry pressure and lower store traffic.
• Full-year 2025 adjusted EBITDA was $78 million, a 35% decrease year-over-year, but exceeded the guidance provided on the last earnings call.
• The company achieved an annualized pro-forma adjusted EBITDA margin of approximately 9% for FY2025, a 200 basis point improvement versus the prior year.
• Fourth quarter 2025 net sales were $347 million, down 8% year-over-year.
• Fourth quarter 2025 net loss was $59 million, compared to a $5 million net loss in the same period last year, primarily due to lower net sales and a $47.9 million deferred tax valuation adjustment.
• Realized $185 million of annualized cost savings through efficiencies in general and administrative, corporate structure, technology, and real estate footprint adaptation.
• The ComfortMode bed, launched in January, has exceeded expectations, outselling plan by 3.5 times with stronger margins.
• The remainder of the new product line, built on consumer research highlighting comfort and value, will be available in March.
• The company's leverage ratio under its credit agreement was 4.1x EBITDAR at year-end, below the amended covenant maximum of 4.5x.
• Sleep Number is implementing a plan to address its liquidity and capital strategy as it moves towards topline growth in the second half of 2026.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed report. While the company exceeded its adjusted EBITDA guidance and saw strong initial success with new product launches, significant declines in net sales and a substantial net loss, coupled with liquidity concerns, indicate ongoing challenges in its turnaround efforts.

Positives

• Exceeded 2025 adjusted EBITDA guidance.
• Realized $185 million of annualized cost savings, with an additional $50 million of annualized fixed cost savings planned for 2026.
• The ComfortMode bed launch in January exceeded expectations, outselling plan by 3.5 times with stronger margins.
• New product line developed in only ten months, significantly faster than the historical two years.
• Strengthened the executive team with new CEO (April 2025), Chief Marketing Officer (May 2025), and Chief Financial Officer (December 2025).
• Leverage ratio of 4.1x EBITDAR is below the amended covenant maximum of 4.5x.

Negatives

• Full-year 2025 net sales decreased 16% to $1.4 billion.
• Fourth quarter 2025 net sales decreased 8% to $347 million.
• Full-year 2025 net loss was $132 million, significantly higher than the $20 million net loss in the prior year.
• Fourth quarter 2025 net loss was $59 million, compared to a $5 million net loss in the prior year, impacted by a $47.9 million deferred tax valuation adjustment.
• Full-year 2025 adjusted EBITDA decreased 35% to $78 million.
• Fourth quarter 2025 adjusted EBITDA decreased 26% to $19 million.
• Gross profit margin declined in both Q4 (55.6% vs 59.9%) and FY (59.0% vs 59.6%), primarily due to a $9.6 million inventory obsolescence charge.
• Net cash used in operating activities was $3 million for FY2025, a decrease of $30 million from the prior year.
• Free cash flow was a use of $18 million for FY2025, a decrease of $21 million from the prior year.
• Negative industry impact at the start of the year and clearance of existing products had an outsized impact on liquidity.

Risks

• Ongoing industry demand pressure and lower store traffic continue to impact sales.
• The negative industry impact at the start of the year, combined with product clearance, has had an outsized impact on liquidity.
• Forward-looking statements are subject to certain risks and uncertainties, as described in the company's SEC filings, which could cause actual results to differ materially.

Future Outlook

Sleep Number anticipates double-digit adjusted EBITDA growth in 2026 as it continues to execute its strategy. The company expects similar strength from the new product line launching in March, with supporting marketing performing well. It is implementing a plan to address liquidity and capital strategy, aiming for topline growth in the second half of 2026.

Management Comments

• "Sleep Number exceeded 2025 guidance provided on our last earnings call."
• "We are still in full turnaround mode and made significant progress against our new product and marketing strategies while continuing to reduce costs."
• "For the full year 2025, pro-forma adjusted EBITDA margin was approximately 9% and anticipate double-digit adjusted EBITDA growth in 2026 as we continue to execute on our strategy."
• "The launch of our ComfortMode bed in January exceeded our expectations and is outselling plan by 3.5 times, with stronger margins than the beds it replaces."
• "Even with the strength of our product and marketing strategies, the negative industry impact at the start of the year plus the clearance of our existing products had an outsized impact on our liquidity."
• "We are implementing a plan to address our liquidity and capital strategy as we move towards topline growth in the second half of the year."

Industry Context

StockSavvy.ai notes that Sleep Number is operating within a challenging industry environment characterized by ongoing demand pressure and lower store traffic, which has negatively impacted sales across the sector. The company's strategic pivot towards new product innovation and aggressive cost management reflects a common response among retailers facing market headwinds, aiming to differentiate and improve efficiency.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Significant net losses and declining sales may concern shareholders, but exceeding EBITDA guidance and new product success offer some optimism for the turnaround strategy. Liquidity concerns and potential capital raise could dilute existing shares or increase debt burden.
• Employees: Restructuring costs and store closures indicate potential job impacts, though the focus on innovation and cost savings aims for long-term stability.
• Customers: New product lines focused on comfort and value, along with simplified shopping, aim to enhance customer satisfaction and address broader needs.
• Creditors: Leverage ratio is close to the covenant maximum, and the company is actively working to address its credit facility and liquidity, indicating potential risk for creditors if the turnaround falters.

Next Steps

• Launch the remainder of the new product line on March 23.
• Implement another $50 million of annualized fixed cost savings in 2026.
• Execute a plan to address liquidity and capital strategy.
• Work with Guggenheim Securities to evaluate opportunities related to the credit facility and balance sheet.
• Anticipate double-digit adjusted EBITDA growth in 2026.
• Move towards topline growth in the second half of 2026.

Key Dates

Recommendation

While Sleep Number exceeded its adjusted EBITDA guidance and showed promising initial results from its new product line and significant cost savings, the overall financial performance for FY2025, including substantial net losses and declining sales, indicates that the turnaround is still in its early stages. Liquidity concerns and the engagement of Guggenheim Securities to address capital structure suggest ongoing financial challenges. The stock is a "hold" as the company navigates these headwinds, with potential for upside if the new product strategy and cost efficiencies translate into sustained profitable growth in 2026, but significant risks remain.

Keywords

Sleep Number, SNBR, earnings, financial results, Q4 2025, FY 2025, net sales, EBITDA, net loss, turnaround strategy, new products, ComfortMode, cost savings, liquidity, capital strategy, corporate governance, retail, mattresses, smart beds